Kocef 250 mg, 500 mg, 1000 mg, INJECTION

Kocef 250 mg, 500 mg, 1000 mg, INJECTION

S4
PDF Leaflet Revision Date: 22 March 2023

API: Ceftriaxone | Company: Dezzo Trading 392

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of infections caused by susceptible organisms.

Dosage (summary)

Adults: 1-2 g once daily; severe cases may require up to 4 g.

Special Populations

  • Elderly
  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Crosses placenta; safety not established. Caution in breastfeeding.

Key Drug Interactions

  • Calcium-containing products
  • Anticoagulants
  • Aminoglycosides

Contraindications

  • Hypersensitivity to ceftriaxone
  • Premature neonates
  • Hyperbilirubinemic newborns

Common side effects

  • Eosinophilia
  • Leucopenia
  • Diarrhoea
  • Rash

Counselling Points

  • Monitor for allergic reactions
  • Avoid calcium-containing solutions
  • Report any severe gastrointestinal symptoms

Serious warnings

  • Serious hypersensitivity reactions
  • Clostridium difficile associated diarrhoea
  • Risk of precipitation with calcium
Important Disclaimer

The Kocef 250 mg, 500 mg, 1000 mg, INJECTION professional information leaflet below is the property of Dezzo Trading 392 and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites